本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Crinetics Pharmaceuticals Inc.

31.20
-0.5700-1.79%
盘后31.200.00000.00%17:24 EDT
成交量:53.36万
成交额:1,663.55万
市值:29.23亿
市盈率:-8.17
高:32.00
开:32.00
低:30.94
收:31.77
数据加载中...
2024/11/08

超过5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/10/17

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/10/16

重要事件披露

Form 8-K - Current report
2024/10/09

重要事件披露

Form 8-K - Current report
2024/10/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/09/27

重要事件披露

Form 8-K - Current report
2024/09/27

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/09/18

重要事件披露

Form 8-K - Current report
2024/09/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/08/26

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/08/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/08/08

重要事件披露

Form 8-K - Current report
2024/08/08

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/07/25

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/07/25

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/07/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/07/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/07/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/07/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/07/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities